Industry: Biotechnology (See others in industry)
Address:| Date | FilingType | Incremental Cash | Link to Raw Filing | |||
|---|---|---|---|---|---|---|
| 2026-03-04 | New | $13,174,977 | $13,174,977 | Equity Only | 06c | SEC link |
| Name | Role |
|---|---|
| Christopher Carlson | Director, Executive |
| Morgan Cheatham | Director |
| David Weinberg | Director, Executive |